Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity

PURPOSE AND EXPERIMENTAL DESIGN: Recombinant human IL-2 (rhIL-2) is a potent cytokine and FDA-approved anticancer drug. However, its clinical use has been limited by severe toxicity, associated primarily with systemic administration with excess protein distributing freely throughout the body. We hyp...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Immunol Immunother
Hoofdauteurs: Chou, Sharon H., Shetty, Aditya V., Geng, Yajun, Xu, Lipeng, Munirathinam, Gnanasekar, Pipathsouk, Anne, Tan, Isaiah, Morris, Timothy, Wang, Bin, Chen, Aoshuang, Zheng, Guoxing
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer-Verlag 2012
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4393711/
https://ncbi.nlm.nih.gov/pubmed/23124508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-012-1364-8
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items